Sign in

CIK 0000318154 · Large accelerated filer

AMGEN INC

Sign in to watch
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
953540776
Phone
(805)447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 4 Grant or award Director acquired 152.04 shares (grant or award)
  2. 4 Grant or award Director acquired 184.61 shares (grant or award)
  3. 4 Grant or award Director acquired 278 shares (grant or award)
  4. 4 Grant or award Director acquired 114.03 shares (grant or award)
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Executive or director change
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale SVP, Business Development sold 3,252 shares at an average $414.05 ($1,346,499)
  11. 144 Insider Sale of Securities
  12. 4 Grant or award VP, Finance & CAO acquired 730 shares (grant or award)
  13. 144 Insider Sale of Securities
  14. 4 Grant or award Director acquired 85.17 shares (grant or award)
  15. 4 Grant or award Director acquired 103.42 shares (grant or award)
  16. 4 Grant or award Director acquired 63.88 shares (grant or award)
  17. 4 Open-market sale SVP, Human Resources sold 3,890 shares at $402.54 ($1,565,898)
  18. 4 Open-market sale SVP & CCO sold 2,970 shares at $402.16 ($1,194,415)
  19. 144 Insider Sale of Securities
  20. 144/A Insider Sale of Securities

Page 1 of 161 · 3,201 filings